S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
OTC:AAWH

Ascend Wellness - AAWH Price Target & Analyst Ratings

$1.09
-0.06 (-5.22%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.08
$1.15
50-Day Range
$1.09
$1.43
52-Week Range
$0.98
$4.23
Volume
120,533 shs
Average Volume
55,925 shs
Market Capitalization
$205.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.75

Ascend Wellness Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 4 Analyst Ratings

Consensus Analyst Price Target

$2.75
152.29% Upside
High Prediction$2.75
Average Prediction$2.75
Low Prediction$2.75
TypeCurrent
3/23/22 to 3/23/23
1 Month Ago
2/21/22 to 2/21/23
3 Months Ago
12/23/21 to 12/23/22
1 Year Ago
3/23/21 to 3/23/22
Consensus Rating
Moderate Buy
Moderate Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$2.75$9.00$9.00$9.00
Predicted Upside152.29% Upside124.44% Upside124.44% Upside124.44% Upside
Get Ascend Wellness Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AAWH and its competitors with MarketBeat's FREE daily newsletter.

AAWH Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AAWH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Ascend Wellness Stock vs. The Competition

TypeAscend WellnessMedical CompaniesS&P 500
Consensus Rating Score
2.75
2.64
2.47
Consensus RatingModerate BuyBuyHold
Predicted Upside152.29% Upside1,990.19% Upside24.71% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/15/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$2.75+135.04%
2/10/2023Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral
10/28/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
7/22/2022Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Randhawa
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
12/7/2021Echelon Wealth Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Semple
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
(Data available from 3/23/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












AAWH Price Target - Frequently Asked Questions

What is Ascend Wellness's consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for Ascend Wellness stock is Moderate Buy based on the current 1 hold rating and 3 buy ratings for AAWH. The average twelve-month price prediction for Ascend Wellness is $2.75 with a high price target of $2.75 and a low price target of $2.75. Learn more on AAWH's analyst rating history.

Do Wall Street analysts like Ascend Wellness more than its competitors?

Analysts like Ascend Wellness more than other Medical companies. The consensus rating for Ascend Wellness is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how AAWH compares to other companies.

Does Ascend Wellness's stock price have much upside?

According to analysts, Ascend Wellness's stock has a predicted upside of 135.04% based on their 12-month price targets.

What analysts cover Ascend Wellness?

Ascend Wellness has been rated by Cantor Fitzgerald, and Needham & Company LLC in the past 90 days.


Stock Ratings Reports and Tools

This page (OTC:AAWH) was last updated on 3/23/2023 by MarketBeat.com Staff